QNTM Valuation

Quantum Biopharma Ltd (QNTM) has a current Price-to-Book (P/B) ratio of 4.10. Compared to its 3-year average P/B ratio of 3.53 , the current P/B ratio is approximately 16.37% higher. Relative to its 5-year average P/B ratio of 2.46, the current P/B ratio is about 66.45% higher. Quantum Biopharma Ltd (QNTM) has a Forward Free Cash Flow (FCF) yield of approximately -24.85%. Compared to its 3-year average FCF yield of -50.02%, the current FCF yield is approximately -50.32% lower. Relative to its 5-year average FCF yield of -50.16% , the current FCF yield is about -50.45% lower.